SLE | RA | SSc | |
---|---|---|---|
Genetics (associated genes important in the function of APCs) | HLA-DRB1/DQB1 [18,19] FcgRIIa and FcgRIIIa [20,21] IRF5 [22-24] STAT4 [27] |
HLA-DRB1 [62-64] FcgRIIIa/b and FcgRIIb [69-72] IRF5 [73] STAT4 [74] |
HLA-DR [127-129] IRF5 [130] STAT4 [132] |
In vivo | Increased transcription of type I IFN regulated genes in peripheral blood cells. [31] Increased levels of IFNa correlated with disease severity. [30] Increased IL-12p70 levels correlating with SLEDAI. [40,41] |
Increased TLR2, 3, 4, 7 expression and presence of endogenous TLR4 ligands in RA synovial tissue. [39, 77-79] Increased transcription of type I IFN regulated genes in blood. [88] IFNa expression in RA synovial tissue. [10] |
Increased transcription of certain type I IFN regulated genes in peripheral blood cells. [135] Endogenous TLR4ligands in serum. [39] Myeloid APCs in diseased skin. [150-151] |
In vitro | ICs from SLE patients induce the release of IFNa by plasmacytoid DCs via TLR7 and TLR9. [36,37] Monocyte-derived and myeloid DCs from SLE patients demonstrate increased maturation and cytokine release. [44] |
RA synovial tissue fibroblasts and monocyte-derived DCs display an increased response to TLR stimulation. [39,80] ICs in synovial fluid induce TNFa release from monocytes. [92,93] TLR8 inhibition prevents spontaneous cytokine release by synovial tissue. [87] |
Interferogenic activity of anti-topoisomerase ICs on plasmacytoid DCs. [137] |
Animal models | TLR7-/- mice do not develop anti-Sm antibodies and have a less severe disease. [49] TLR7 over expression results in increased autoimmunity. [52] IFNaR-/- mice develop less severe lupus-like disease. [48] |
FcgRIII-/- mice are protected from IC-induced arthritis. [97, 99] FcgRII-/- mice are more susceptible and have a worse arthritis. [101] Knocking out of TLR4 or the blockade of TLR4 reduces arthritis in multiple models. [102, 104] Syk inhibitors suppress inflammation and bone erosion. [100] |
UCD 200 chicken, Tsk2 mice and bleomycin induced SSc show mononuclear cell infiltrates and autoantibody production. [152-156] Signaling through TLR4 in the bleomycin model induces autoantibody production. [158] |
Treatment (drugs emphasizing the role played by APCs and their receptors) | HCQ and glucocorticoids [55,56] Anti-IFNa antibodies [57] Abetimus sodium [58] |
HCQ and glucocorticoids [113-116] Abatacept [110-112] Chaperonin 10 [118] Syk inhibitor, R788 [121] |